Claims of high protein, lean muscle maintenance and immunity support, and a supplement described as "imported from Europe for purity": these are among the statements the Food Safety and Standards Authority of India (FSSAI) has asked companies to justify in a run of notices and advisories over recent weeks.
The regulator's latest actions focus on the health supplement and nutraceutical market, where it says labelling and advertising rules are not being followed.
Questions over protein claims
On 8 October, FSSAI said it had issued notices to Dr Reddy's, Nestlé Health Science, Tirupati Wellness, Flipkart, Amazon and Netmeds. According to reports, the claims under scrutiny covered high protein content, lean muscle maintenance, muscle strength, immunity support and energy metabolism.
Each company was asked to explain why no action should be taken against it. Flipkart and Amazon were named as sellers of the product.
Herbal products and warning labels
A week later, on 15 October, FSSAI issued an advisory saying several makers of nutraceuticals, health supplements and special dietary foods were not following mandatory labelling and warning requirements for plant and botanical ingredients and their extracts.
It gave examples. Products containing neem should carry a caution against use by those planning to conceive, and products with Coleus forskohlii a caution against use by children under five. NutraIngredients reported that FSSAI and the Ministry of AYUSH had identified 16 botanical ingredients that need warning statements.
Not the first action
In July, FSSAI ordered the sale of two products, FOLINEURO syrup and Neuherbs TRUE VITAMIN, to be stopped over misleading claims, according to The Hawk. In one case, FSSAI said the product was labelled a "Nutritional Food Supplement", a category that does not exist under its 2016 regulations. The company was told to remove the claims from labels and advertisements and submit an action taken report within 30 days.
States are also looking closer. Business Standard reported in early October that Maharashtra's FDA planned wider scrutiny of supplement contents, labelling and sales after being alerted to products marketed with false or exaggerated claims.
Date& Action | Regulatory Step | Main Concern |
|---|---|---|
July – Sales stopped | Two products restricted | Misleading health claims |
8 October-Notices issued | Major companies questioned | Protein and immunity claims |
Beyond supplements
On 19 October, FSSAI separately issued notices to Nestlé India over claims on two infant nutrition products and to Zydus Wellness over claims on Complan, including "2X Faster Growth". Nestlé India said it had already submitted detailed responses on the label issues raised.
What labels must show
FSSAI's rules require supplement labels to state the product category, such as "nutraceutical" or "health supplement", along with the amount of relevant ingredients and recommended usage. Its Advertising and Claims Regulations, 2018, bar claims that food can prevent, alleviate, treat or cure a disease unless specifically permitted, and require scientific backing for health claims.
